50 search results for: pediatric
Jorge F. Maspero, FAAAAI, FCCP, MD
Clinical Research Director for Allergy, Immunology, and Respiratory Medicine | Fundación Cidea in Buenos Aires; Head of Pediatric Allergy Unit | Buenos Aires Deutsches Hospital
Christos Tzivinikos, MD
Christos Tzivinikos, MD, is a consultant pediatric gastroenterologist and founder of the Gastroenterology Department at Al Jalila Children’s Specialty Hospital in Dubai, United Arab Emirates
Antonella Cianferoni, MD, PhD
Associate Professor in Pediatrics | Perelman School of Medicine, University of Pennsylvania; Medical Director of the Food Allergy Immunotherapy Program | Children’s Hospital of Philadelphia, Pennsylvania, United States
Lawrence F. Eichenfield, MD
Vice Chair of the Department of Dermatology | University of California San Diego (UCSD) School of Medicine; Chief of Pediatric and Adolescent Dermatology | Rady Children’s Hospital San Diego, California, United States
Peter Lio, MD
Clinical Professor of Dermatology at the Icahn School of Medicine at Mount Sinai, NY; Clinical Assistant Professor of Dermatology & Pediatrics at Northwestern University Feinberg School of Medicine, Chicago, Illinois, US
Seema Aceves, MD, PhD
Professor of Pediatrics and Medicine in the Division of Allergy and Immunology | University of California, San Diego; Director of the Eosinophilic Gastrointestinal Disorders Clinic | Rady Children’s Hospital–San Diego, California, United States
Prevalence of Food Allergy and Other Atopic Comorbidities in Children With AD
In this highlight video from the October 2024 ADVENT symposium at EAPS in Vienna, Austria, Dr Mark Boguniewicz discusses the prevalence of food sensitization and food allergy in pediatric patients with AD, clarifying the difference between the two. Dr Boguniewicz also discusses the prevalence of other atopic comorbidities in children with AD
Identification and Management of AD Uncontrolled With Topical Therapies in Children
In this expert interview video focusing on topics from the October 2024 ADVENT symposium at EAPS in Vienna, Austria, Dr Perla Lansang discusses how to identify pediatric patients with AD uncontrolled with topical therapies, considerations for the next step in care for these patients, and the potential benefits of early intervention with systemic treatment
Cumulative Impact of Uncontrolled Atopic Dermatitis: Skin Inflammation as the Tip of the Iceberg
Prof Jean-David Bouaziz describes the multifaceted burden of atopic dermatitis, beyond what can be seen on the skin, at EADV 2025.
2025 ADVENT Forum | Joint Plenary Session: A View into the Life of Our Patients Video
This cross-TA plenary session addressed challenges in type 2 inflammation-driven diseases. Esteemed faculty, including Profs Klaus Rabe, Sharon Dell, Anju Peters, Milli Gupta, Eric Simpson, Stella Lee, and moderator Oscar Palomares, discussed strategies to enhance quality of life, reduce disease burden, and prioritize patient-centered care.
Charting the Future: Preventing the Atopic March
In this clip from the April WCPD 2025 symposium, Dr Eulàlia Baselga discusses data identifying atopic dermatitis as the first diagnosed atopic disease and the start of the atopic march.
KOL Video Interview – Dr Paula Luna
In this exclusive video interview, Dr Paula Luna discusses how disease modification can be defined in AD and how IgE may be used as a biomarker in AD.
